MacroCure was a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young healthy donor blood
Looking for a particular Macrocure employee's phone or email?
The Macrocure annual revenue was $156000 in 2026.
Mitchell Shirvan is the CEO of Macrocure.
5 people are employed at Macrocure.
Macrocure is based in Petah Tiqwa, Central District.
The NAICS codes for Macrocure are [3254, 32, 325412, 325, 32541].
The SIC codes for Macrocure are [283, 28].